Evidence map›Paper›PMID 33044128›Full record

ArticleCirculation research2020

ATAC-Seq Reveals an

Giselle Galang, Ravi Mandla, Hongmei Ruan, Catherine Jung, Tanvi Sinha, Nicole R Stone, Roland S Wu, Brandon J Mannion, Prasanna K R Allu, Kevin Chang and 5 more

Open access · greenAbstract read
In one paragraph

Article in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Development of the Cardiac Conduction System.Advances in experimental medicine and biology · 2024
    Article
  15. Review
  16. Molecular therapy. Nucleic acids · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Giselle GalangCardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Ravi Mandla *Cardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Hongmei Ruan *Cardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Catherine JungCardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Tanvi SinhaCardiovascular Research Institute (T.S., R.S.W., B.L.B., V.V.), University of California, San Francisco.
Nicole R StoneGladstone Institute of Cardiovascular Disease, San Francisco, CA (N.R.S.).
Roland S WuCardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Brandon J MannionEnvironmental and Systems Biology Division, Lawrence Berkeley National Laboratory, CA (B.J.M., L.A.P.).
Prasanna K R AlluCardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Kevin ChangSchool of Medicine (K.C.), University of California, San Francisco.
Ashwin RammohanCardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Marie B ShiCardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Len A PennacchioEnvironmental and Systems Biology Division, Lawrence Berkeley National Laboratory, CA (B.J.M., L.A.P.).
Brian L BlackCardiovascular Research Institute (T.S., R.S.W., B.L.B., V.V.), University of California, San Francisco.
Vasanth VedanthamCardiology Division (G.G., R.M., H.R., C.J., R.S.W., P.K.R.A., A.R., M.B.S., V.V.), University of California, San Francisco.
Dr. M.G.R. Educational and Research Institute · INUniversity of California, San Francisco · USLawrence Berkeley National Laboratory · USGladstone Institutes · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kate Taylor Shumate · 1999 to 2026
$209.7M
Generation of an In Vivo Human Genome Transcriptional Enhancer DatasetR01HG003988 · NHGRI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI Len Alexander Pennacchio · 2006 to 2026
$24.1M
Project 3: Control of cardiac transcription by MEF2 and myocardinP01HL146366 · NHLBI · J. DAVID GLADSTONE INSTITUTES · PI SRIVASTAVA, DEEPAK · 2019 to 2023
$13.7M
Regulation of cardiovascular transcriptionR01HL064658 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BLACK, BRIAN L · 2000 to 2019
$5.4M
Identification and application of regulatory elements for heart regenerationR01HL136182 · NHLBI · DUKE UNIVERSITY · PI BLACK, BRIAN L, POSS, KENNETH D · 2017 to 2020
$3.1M
A Regenerative Approach to Cardiac PacingDP2HL152425 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VEDANTHAM, VASANTH · 2019 to 2019
$2.4M
NCI NIH HHS P30 CA082103NHGRI NIH HHS R01 HG003988NHLBI NIH HHS DP2 HL152425NHLBI NIH HHS P01 HL146366NHLBI NIH HHS R01 HL064658NHLBI NIH HHS R01 HL136182
6 · The paper itself

Abstract

rationaleCardiac pacemaker cells (PCs) in the sinoatrial node (SAN) have a distinct gene expression program that allows them to fire automatically and initiate the heartbeat. Although critical SAN transcription factors, including Isl1 (Islet-1), Tbx3 (T-box transcription factor 3), and Shox2 (short-stature homeobox protein 2), have been identified, the

objectiveTo define the epigenetic profile of PCs using comparative ATAC-seq (assay for transposase-accessible chromatin with sequencing) and to identify novel enhancers involved in SAN gene regulation, development, and function. METHODS AND

resultsWe used ATAC-seq on sorted neonatal mouse SAN to compare regions of accessible chromatin in PCs and right atrial cardiomyocytes. PC-enriched assay for transposase-accessible chromatin peaks, representing candidate SAN regulatory elements, were located near established SAN genes and were enriched for distinct sets of TF (transcription factor) binding sites. Among several novel SAN enhancers that were experimentally validated using transgenic mice, we identified a 2.9-kb regulatory element at the

conclusions(1) PCs have distinct regions of accessible chromatin that correlate with their gene expression profile and contain novel SAN enhancers, (2)

Indexed as

Biological ClocksChromatin Immunoprecipitation SequencingEnhancer Elements, GeneticHeart RateAction PotentialsAnimalsArrhythmia, SinusEpigenesis, GeneticFemaleGene Expression Regulation, DevelopmentalGestational AgeHumansLIM-Homeodomain ProteinsMaleMice, Inbred C57BLMice, Transgenicinsulin gene enhancer binding protein Isl-1LIM-Homeodomain ProteinsTranscription Factorschromatinheart ratemicesinoatrial nodezebrafish

Identifiers

PMID33044128
PMCPMC7720845
OpenAlexW3092428974

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.